Explore the Potential with AI-Driven Innovation
This extensive focused library is tailor-made using the latest virtual screening and parameter assessment technology, operated by the Receptor.AI drug discovery platform. This technique is more effective than traditional methods, offering compounds with improved activity, selectivity, and safety.
From a virtual chemical space containing more than 60 billion molecules, we precisely choose certain compounds. Our collaborator, Reaxense, aids in their synthesis and provision.
The library includes a list of the most promising modulators annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Also, each compound is presented with its optimal docking poses, affinity scores, and activity scores, providing a comprehensive overview.
We utilise our cutting-edge, exclusive workflow to develop focused libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
The procedure entails thorough molecular simulations of the catalytic and allosteric binding pockets, accompanied by ensemble virtual screening that factors in their conformational flexibility. When developing modulators, the structural modifications brought about by reaction intermediates are factored in to optimize activity and selectivity.
Our library stands out due to several important features:
partner
Reaxense
upacc
Q8NB90
UPID:
AFG2A_HUMAN
Alternative names:
AFG2 AAA ATPase homolog A; Ribosome biogenesis protein SPATA5; Spermatogenesis-associated factor protein; Spermatogenesis-associated protein 5
Alternative UPACC:
Q8NB90; C9JT97; Q86XW1; Q8NI20; Q8TDL7
Background:
The ATPase family gene 2 protein homolog A, also known as Ribosome biogenesis protein SPATA5, plays a pivotal role in the cytoplasmic maturation of pre-60S ribosomal particles. It facilitates the release of RSL24D1/RLP24, working alongside AFG2B, AIRIM, and CINP. This protein is also implicated in mitochondrial transformations during spermatogenesis, highlighting its versatile functions in cellular processes.
Therapeutic significance:
Linked to a neurodevelopmental disorder characterized by intellectual disability, intractable epilepsy, microcephaly, abnormal muscle tone, and sensorineural hearing loss, understanding the role of ATPase family gene 2 protein homolog A could open doors to potential therapeutic strategies.